Owlstone Medical

company

About

Owlstone Medical is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection.

  • 101 - 250

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$35M
Industries
Emergency Medicine,Health Care,Health Diagnostics,Medical Device
Founded date
May 1, 2004
Number Of Employee
101 - 250
Operating Status
Active

Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory disease, and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs.

The company’s Breath Biopsy® platform has introduced a new diagnostic modality making it possible to discover novel non-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA Breath Sampler ensures a reliable collection of breath samples. The volatile organic compounds (VOCs) present in the breath are analyzed using proven microchip chemical sensor technology (FAIMS) to detect biomarkers of disease.

The Breath Biopsy platform can be used in clinical diagnostics and precision medicine with applications in cancer and a wide range of other medical conditions. Highly sensitive and selective, these tests allow for early diagnosis when treatments are more effective and more lives can be saved.

Owlstone Medical is currently developing tests for lung and colorectal cancer, two of the most common cancer killers worldwide, and for asthma stratification by the therapeutic response. The company also Breath Biopsy products and services to academic, clinical, and pharma partners who want to develop breath-based diagnostics for their own applications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$35M
Owlstone Medical has raised a total of $35M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2018 Series Unknown $35M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Owlstone Medical is funded by 1 investors. Foxconn Technology Group are the most recent investors.
Investor Name Lead Investor Funding Round
Foxconn Technology Group Series Unknown